AlloVir, Inc. (ALVR)
Mar 18, 2025 - ALVR was delisted (reason merged into KLRS)
9.81
+0.39 (4.14%)
Inactive · Last trade price
on Mar 18, 2025
AlloVir Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for AlloVir.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for AlloVir.
Recommendation Trends
Rating | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 | Jan '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
Buy | 3 | 3 | 3 | 3 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 3 | 0 |
Sell | 0 | 0 | 0 | 0 | 2 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 5 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $23 → $12 | Hold → Sell | Downgrades | $23 → $12 | +17.23% | Jan 5, 2024 |
B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $391 → $23 | Strong Buy → Sell | Downgrades | $391 → $23 | +134.45% | Dec 26, 2023 |
Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $460 → $23 | Buy → Hold | Downgrades | $460 → $23 | +134.45% | Dec 22, 2023 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $23 | Buy → Hold | Downgrades | $23 | +134.45% | Dec 22, 2023 |
Piper Sandler | Piper Sandler | Buy → Hold Downgrades $621 → $35 | Buy → Hold | Downgrades | $621 → $35 | +251.68% | Dec 22, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.30
EPS Next Year
-0.45
from -0.30
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.05 | -0.46 |
Avg | -0.30 | -0.45 |
Low | -0.49 | -0.43 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.